Researchers Reach Femtogram-Level Chemical Characterization
ePT--the Electronic Newsletter of Pharmaceutical Technology
Combining atomic force microscopy and infrared spectroscopy, scientists at the University of Illinois have demonstrated a method for simultaneous structural and chemical characterization of samples at the femtogram (10-15g) level.
Champaign, IL (Mar. 27)-Combining atomic force microscopy and infrared spectroscopy, scientists at the University of Illinois have demonstrated a method for simultaneous structural and chemical characterization of samples at the femtogram (10-15g) level.
Their technique is based on a silicon cantilever probe in an atomic force microscope. The probe integrates a heater-thermometer that is controlled in the 25–1000 °C temperature range, which allows extraction of very small samples of material for imaging. To analyze a sample, the heater temperature is raised to slightly above the melting point of the sample material. The material is then analyzed by Raman or Fourier transform infrared (FTIR) spectroscopic imaging.
“We anticipate this approach will help bridge the gap between nanoscale structural analysis and conventional molecular spectroscopy in a manner widely useful to most analytical laboratories,” said William P. King, professor of mechanical science and engineering at the University of Illinois.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
